Sox5 regulates beta-cell phenotype and is reduced in type 2 diabetes

Sox5 调节 β 细胞表型,在 2 型糖尿病中减少

阅读:9
作者:A S Axelsson, T Mahdi, H A Nenonen, T Singh, S Hänzelmann, A Wendt, A Bagge, T M Reinbothe, J Millstein, X Yang, B Zhang, E G Gusmao, L Shu, M Szabat, Y Tang, J Wang, S Salö, L Eliasson, I Artner, M Fex, J D Johnson, C B Wollheim, J M J Derry, B Mecham, P Spégel, H Mulder, I G Costa, E Zhang, A H Ro

Abstract

Type 2 diabetes (T2D) is characterized by insulin resistance and impaired insulin secretion, but the mechanisms underlying insulin secretion failure are not completely understood. Here, we show that a set of co-expressed genes, which is enriched for genes with islet-selective open chromatin, is associated with T2D. These genes are perturbed in T2D and have a similar expression pattern to that of dedifferentiated islets. We identify Sox5 as a regulator of the module. Sox5 knockdown induces gene expression changes similar to those observed in T2D and diabetic animals and has profound effects on insulin secretion, including reduced depolarization-evoked Ca2+-influx and β-cell exocytosis. SOX5 overexpression reverses the expression perturbations observed in a mouse model of T2D, increases the expression of key β-cell genes and improves glucose-stimulated insulin secretion in human islets from donors with T2D. We suggest that human islets in T2D display changes reminiscent of dedifferentiation and highlight SOX5 as a regulator of β-cell phenotype and function.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。